The natural resistance to doxorubicin of 15 human renal carcinoma cell lines was analyzed and compared to proliferative activity and expression of P-glycoprotein. We found a significant negative correlation between proliferative activity and natural resistance to doxorubicin, as well as between prol
Pre-Treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin
โ Scribed by Katia Scotlandi; Massimo Serra; Maria Cristina Manara; Pier-Luigi Lollini; Daniela Maurici; Donatella Del Bufalo; Nicola Baldini
- Book ID
- 102866906
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 769 KB
- Volume
- 58
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
โฆ Synopsis
N-methylformamide (NMF), a powerful differentiating agent, has been extensively used in experimental and preclinical cancer chemotherapy studies, alone or in association with conventional anti-cancer drugs. To evaluate the use of this molecule in the treatment of osteosarcoma (OS), we have analyzed the effects of NMF and doxorubicin (DXR) on DXRsensitive and -resistant human 0 s cell lines. Our study shows that NMF exerts remarkable effects on cell proliferation and, in Saos-2 and SARG cells, also induces differentiation, as shown by increasing alkaline phosphatase activity. Moreover, NMF increases the cytotoxic activity of D X R when administered after the drug, in both DXR-sensitive and -resistant cells. However, when this agent is given before DXR. it enhances P-glycoprotein expression in U-2 0 s cell lines. This over-expression is associated with reduced DXR accumulation within cells and with significant enhancement of resistance to DXR.
๐ SIMILAR VOLUMES